Track-1 : Cardiology and Hypertension
Cardiology is a medical specialty and a branch of internal medicine concerned with disorders of the heart. It deals with the diagnosis and treatment of such conditions as congenital heart defects, coronary artery disease, electrophysiology, heart failure and valvular heart disease. Subtopics of the cardiology include cardiac electrophysiology, echocardiography, interventional cardiology and nuclear cardiology. Hypertension is Blood pressure is the force that a person's blood exerts against the walls of their blood vessels. For cardiovascular diseases, including stroke, heart attack, heart failure, and aneurysm hypertension is a primary risk factor. Treatment drugs for hypertension include diuretics, including thiazides, chlorthalidone, and indapamide, beta-blockers and alpha-blockers, calcium-channel blockers, central agonists, peripheral adrenergic inhibitor, vasodilators, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers.
Track-2 : Congenital Heart Disease (CHD) and Pediatric Cardiology
Heart failure is a complex clinical disorder which is a outcome of various primary and secondary causes, and shared pathways of disease progression, relating with considerable mortality, morbidity and cost. Heart failure in pediatrics is most commonly associated with coexistence of congenital heart disease, with different risks depending on the specific type of malformation. The signs and symptoms in children include, poor growth, feeding difficulties, respiratory track disorders, exercise intolerance, and fatigue, and is associated with circulatory, neurohormonal imbalance, and molecular abnormalities. Congenital heart disease is frequently associated with ventricular dysfunction, volume or pressure overload.
Heart Failure in pediatric patients with CHD has various causes, some of which overlap with the causes of cardiomyopathy, resulting in both distinct and shared mechanisms leading to ventricular dysfunction and the clinical manifestation of heart failure. We focus on basic, translational, and clinical research as it applies to heart failure in pediatric patients with CHD.
Track-3 : Hypertension and Stroke
High blood pressure damages arteries throughout the body by creating a condition where they can burst or aggregate more easily. Arteries in the brain due to high blood pressure, puts you at much higher risk for stroke which is why managing high blood pressure is critical to reduce your chance of having a stroke. Antihypertensive treatment plays importance in reducing the incidence of stroke mortality and morbidity.
Track-4 : Hypertension, Diabetes and Obesity
Hypertension is a common in patients with diabetes. the risk of macrovascular and microvascular complications are reduced by adequate control of blood pressure. The use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, thiazide diuretics, beta blockers, calcium channel blockers, dihydropyridine calcium channel blockers will keeps blood pressure in controlled state. Combination therapy with multiple antihypertensive agents is suggested for many patients with diabetes.
Obesity associated with increased visceral adiposity is accounting for 65% to 75% of the risk for human primary hypertension. Obesity hypertension is mainly initiated by natriuresis which is impaired by increased renal tubular sodium reabsorption. The abnormal kidney function and increased blood pressure during development of obesity hypertension include physical compression of the kidneys by fat, activation of the renin angiotensin aldosterone system, and increased sympathetic nervous system activity.
Track-5 : Cardiometabolic Diseases and Cancer
The scientific goal of this track is to understand the underlying causes and pathophysiology cardiometabolic diseases like of obesity, diabetes, and as well as pursuing effective and safe interventions and therapeutics. This includes expertise in the central nervous system that controls appetite and energy expenditure, pancreas function, and adipose tissue function. Cardio-oncology describes the efforts to prevent or treat patients with cancer who are facing with heart problems due to cancer treatments. Although many cancer patients also have health conditions related to lung disease, infections or kidney disease, the rise of cardiac diseases in these patients has led to the growth of this new field. Cardio-oncology involves oncologists, cardiologists and researchers.
Track-6 : Heart Failure and Cardiomyopathies
Cardiomyopathies are a heterogeneous group of heart muscle diseases, including dilated (DCM), hypertrophic (HCM), restrictive (RCM), arrhythmogenic right ventricular (ARVC), and non‐classified cardiomyopathies that frequently present as the syndrome of heart failure. The variety of causes, multiple underlying pathophysiological mechanisms and different phenotypic expressions influence their presentation and response to treatment. Although patients with cardiomyopathies have been represented in clinical trials, distinct features of their therapeutic responses, relative to other aetiologies of HF, remain unknown.
Track-7 : Cardiovascular Medicine
Cardiovascular Medicine gives the information related to the areas where researchers expect great progress are:
Role of PCSK9 inhibitors;
Recognition of the impact of inflammation on cardiovascular disease;
The percutaneous placement of aortic and mitral valves; and
The larger role for wearable and implantable devices and the data they collect
The most prominent disease areas where there will be new innovations and late-breaking clinical trials are atrial fibrillation heart failure, diabetes and cardio-oncology.
Track-8 : Cardiac Pharmacology and Therapeutics
Pharmacology Research & Perspectives focuses on cardiac pharmacology and demonstrates the breadth of work in the area of cardiology. From characterizing the effects of an immunosuppressive drug on cardiac metabolism to advances in understanding of the mechanism of action of beta adrenergic and angiotensin inhibiting drugs to systems models for the characterization of clinical electrocardiographic QT prolongation, the researchers provides original cardiovascular pharmacology research. It covers both the newer drugs and research advances in understanding of older drugs. Understanding mechanism of action of new drugs allows the anesthetists to incorporate new drugs into their clinical practices.
Track-9 : Heart Disease and Pregnancy
In 1% to 4% of pregnancies, cardiovascular disease has been estimated to be present. The incidence of pregnancies in women with heart disease is rising, mainly due to an increased number of women with congenital heart disease reaching childbearing age; advancing maternal age; and increased incidence of. Although most cardiac conditions are well tolerated during pregnancy and women can deliver safely with favorable outcomes, there are some cardiac conditions that have significant maternal and fetal morbidity and mortality.
Track-10 : Cardiac Surgery and Nursing
Cardiac surgery has been a vibrant field since the early pioneering procedures were attempted, became successful, and eventually reproducible. From the successful closure of a patent ductus arteriosus discovery and innovation have been the hallmarks of cardiac surgery. The development of safe myocardial preservation with solutions to protect the heart opened the surgical world to complex prolonged cardiac procedures and made cardiac transplantation feasible. Routine preservation of myocardial structure and function for periods of several hours has been achieved. Cardiac nursing is dedicated to treating and caring for patients with a variety of heart diseases or conditions. Understanding of normal cardiac anatomy and physiology, keen assessment and monitoring skills, vast knowledge about cardiac disease and conditions, and ongoing education related to recommended prevention methods and treatment options are included in cardiac nursing profession. Cardiac nurses work in inpatient or outpatient wards, care for medical or surgical patients or help them manage chronic disease.
Track-11 : Cardiac Rehabilitation and Healthcare
Health education, advice on cardiovascular risk reduction, physical activity and stress management are the interventions offered to patients with heart diseases in cardiac rehabilitation. Cardiac rehabilitation reduces mortality, morbidity, unplanned hospital admissions in addition to improvements in exercise capacity, quality of life and psychological well-being is increasing, and it is now recommended in international guidelines. Cardiac rehabilitation is the evidence of its benefit and effects on cardiovascular mortality, morbidity and quality of life.
Track-12 : Stem Cell and Cardiac Tissue Regeneration
Stem cell-based therapy has acquired a promising role in regenerative medicine. The application of novel cell therapeutics for the treatment of cardiovascular diseases could potentially achieve the ambitious aim of effective cardiac regeneration. Despite the highly positive results from preclinical studies, data from phase I/II clinical trials are inconsistent and the improvement of cardiac remodeling and heart performance was found to be quite limited. The major issues which cardiac stem cell therapy is facing include inefficient cell delivery to the site of injury, accompanied by low cell retention and weak effectiveness of remaining stem cells in tissue regeneration.
According to preclinical and clinical studies, various stem cells (adult stem cells, embryonic stem cells, and induced pluripotent stem cells) represent the most promising cell types so far. Beside the selection of the appropriate cell type, researchers have developed several strategies to produce “second-generation” stem cell products with improved regenerative capacity. Genetic and nongenetic modifications, chemical and physical preconditioning, and the application of biomaterials were found to significantly enhance the regenerative capacity of transplanted stem cells.
Track-13 : Clinical Case Reports on Cardiology
Cardiology deals with the scientific studies on various types of anomalies related to heart as well as circulatory system. It is also a branch of internal medicine. The aim of cardiological studies covers the diagnosis and treatment of disorders of heart, which includes coronary artery disease, congestive heart failure, congenital defects, heart failure etc.
The specialists in the field of Cardiology are called cardiologists. There are two types of cardiologists namely, adult cardiologists, who are adequately trained to treat adults and another type is pediatric cardiologists, who are trained to treat children. However, both types of physicians are having the immense importance in both clinical and experimental studies, which they publish in the form of case report. Such case report describes and provides a detail insight into disorders related to heart and thereby, contributes a landmark guidance for other cardiologists, which helps to determine more safe and secure cardiological therapeutics.